Eton Pharmaceuticals reported quarterly EPS of $0.05 versus the Zacks consensus of $0.12, missing by $0.07 (about 58%). The result compares with a loss of $0.02 a year ago, so EPS improved year-over-year but fell short of analyst expectations, likely to pressure the stock near term.
Eton Pharmaceuticals reported quarterly EPS of $0.05 versus the Zacks consensus of $0.12, missing by $0.07 (about 58%). The result compares with a loss of $0.02 a year ago, so EPS improved year-over-year but fell short of analyst expectations, likely to pressure the stock near term.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
moderately negative
Sentiment Score
-0.55
Ticker Sentiment
